Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study

PURPOSE: To compare one-year treatment outcomes of intravitreal aflibercept (IVA) and intravitreal ranibizumab (IVR) for treatment of myopic choroidal neovascularization (mCNV). METHODS: The medical records of a total of 30 eyes diagnosed with mCNV and underwent IVA or IVR treatment for a minimum on...

Descripción completa

Detalles Bibliográficos
Autores principales: Erden, Burak, Bölükbaşı, Selim, Baş, Emine, Çakır, Akın
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012232/
https://www.ncbi.nlm.nih.gov/pubmed/32082619
http://dx.doi.org/10.1155/2019/8639243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012232/
https://www.ncbi.nlm.nih.gov/pubmed/32082619
http://dx.doi.org/10.1155/2019/8639243

Ejemplares similares